Steve Pakola

Steve Pakola

Company: REGENXBIO

Job title: Chief Medical Officer

Seminars:

Utilizing Gene Therapy to Induce Long-Term Treatment of Wet AMD & Diabetic Retinopathy 10:05 am

Outline the RGX-314 gene therapy program Discussing why suprachoroidal/subretinal delivery are optimal for this treatment Reviewing the current clinical data from Phase III clinical trialsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.